Discovery of calnexin protein’s role in the blood-brain barrier could lead to new MS treatments.

A discovery led by scientists at the University of Alberta and McGill University is providing hope of a new therapeutic target in Multiple Sclerosis (MS) patients, which could one day be used to prevent the symptoms and progression of the disease.

Classified as: MS treatments, calnexin protein, School of Human Nutrition, Luis Agellon
Published on: 8 Mar 2018
Back to top